Not finding it? Sign in to also search OpenAlex live.
-
Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1-Mutated AML - the SAL/AMLCG Vincent Trial
Leo Ruhnke, Christoph Schliemann, Lars R. Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, +26 more
2citations -
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, Gesine Bug, Martina Margrit Crysandt, Sabine Dressler, +19 more
70citations -
Fedratinib in combination with CC-486, an oral hypomethylating agent, in patients with accelerated phase myelofibrosis: Results from the phase I/II famy trial2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Nadja Jaekel, Susann Schulze, Christina Zahn, Andreas Wienke, Michael Richter, Steffen Koschmieder, +5 more
1citations -
DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy
Olga Grishina, Claudia Schmoor, Caroline Sellner, Björn W. Hackanson, Jan‐Henrik Mikesch, Iordanis Deligiannis, +28 more
0citations -
Elevation of fetal hemoglobin is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC leukemia group, gimema and german MDS study group
Julia Stomper, Michal Kiciński, Tobias Ma, Sylvain Chantepie, Richard Noppeney, Mario Luppi, +16 more
0citations -
Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies2023 Leukemia article Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access cited by 2 patents
Jessie S. Kroonen, Ilona J. de Graaf, Sumit Kumar, Dennis F.G. Remst, Anne K. Wouters, Mirjam H.M. Heemskerk, +1 more
22citations -
RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress response2026 Molecular Cell article Biochemistry, Genetics and Molecular Biology RNA and protein synthesis mechanisms Open access
Shubo Zhao, Chloe S. Palma-Chaundler, Carla M. Engel, Jacqueline Cordes, Daniel Nixdorf, Michael Y. Luo, +19 more
8citations -
The implication of TET1, miR-200, and miR-494 expression with tumor formation in colorectal cancer: through targeting Wnt signaling2024 Molecular Biology Reports article Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation Open access
Raziye Tajali, Neda Zali, Fatemeh Naderi Noukabadi, Morteza Valinezhad, Farnaz Ghasemian, Makan Cheraghpour, +2 more
3citations -
Environmentally-induced DNA methylation is inherited across generations in an aquatic keystone species ( Daphnia magna )2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access
Nathalie Feiner, Reinder Radersma, Louella J. Vasquez, Markus Ringnér, Björn Nystedt, Amanda Raine, +3 more
3citations -
108P Epigenetic regulation of the putative breast cancer metastasis suppressor gene SCN4B2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access
Lars Hilgers, Arndt Hartmann, Peter Andreas Fasching, Sophia Villwock, Lorna Moll, Sébastien Roger, +3 more
0citations -
The implication of TET1, miR-200 and miR-494 expression with tumor formation in colorectal cancer: through targeting WNT signaling2024 Research Square preprint Biochemistry, Genetics and Molecular Biology MicroRNA in disease regulation Open access
Raziye Tajali, Neda Zali, Fatemeh Naderi Noukabadi, Morteza Valinezhad, Farnaz Ghasemian, Makan Cheraghpour, +2 more
0citations -
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft2023 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Luca Vinci, Christian Flotho, Peter Noellke, Dirk Lebrecht, Riccardo Masetti, Válerie de Haas, +25 more
14citations
18 results